Keywords: ucb, sells, somatostatine, eumedica, belgian, drugmaker, agreed

UCB sells Somatostatine to Eumedica

Article | 16 February 2009

Print This

Belgian drugmaker UCB has agreed to sell the worldwide rights for Somatostatine-UCB to France's Eumedica. UCB will receive a cash ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in